postmenopausal
postmenopausal
1. Effect of transdermal hormone replacement therapy on the monocyte chemoattractant protein-1 concentrations and other vascular inflammatory markers and on endothelial function in postmenopausal women.
(经皮雌激素替代治疗对单核细胞化学吸附蛋白-1浓度和其他血管炎症标记以及绝经后女性内皮功能的影响。
2. In 1996, the USPSTF did not find enough evidence to recommend for or against routine osteoporosis screening in postmenopausal women.
1996年，USPSTF没有发现足够的证据以建议或反对停经妇女进行例行的骨质疏松筛检。
3. Akesson and colleagues studied the dietary and lifestyle patterns of 24,444 postmenopausal women enrolled in a clinical trial in 1997.
1997年，A和他的同事们研究了志愿做临床试验的24444名绝经妇女的饮食和生活习惯。
4. This hypothesis was recently confirmed by a study that found a reduced risk of inasie breast cancer among postmenopausal women with high lignan leels in their diet, Clael-Chapelon said.
Clael-Chapelon博士说，这种假说被近来的一项研究所证实，研究发现在绝经后的妇女中，饮食中含有高水平的木脂素类的人乳腺浸润性癌风险降低。
5. The polymorphism of CTR gene was associated with BMD in postmenopausal women.
CTR基因多态性与绝经后妇女BMD存在一定的关联。
6. The FDA approved the drug in 1997 for preventing osteoporosis in postmenopausal women, and studies have shown that raloxifene appears to protect some women from developing breast cancer.
fda在1997年批准了该药，开始时用于为绝经期妇女预防骨质疏松。 研究表明，raloxifene似乎可以保护某些妇女不得乳腺癌。
7. HERS was a randomized, blinded, placebo-controlled trial of estrogen plus progestin in older postmenopausal women with heart disease.
HERS是一个随机、双盲、设有安慰剂对照的试验，观察了雌激素和孕激素对患有心脏病的老年妇女的影响。
8. "Estrogens are helpful in postmenopausal women," she said, but stressed that 2 published trials found that oral contraceptie use showed no benefit to bone health in anorexic women with amenorrhea.
“雌激素对经绝后的女性是有好处的，”她说，但是她又强调了两个公共案例表明口服避孕药对无月经的神经性厌食症女性患者的骨健康是没有好处的。
9. The elevation of day 3 FSH, LH levels was not significant until the AOV group (P=0.009,P=0.027 respectively), and the drop of E 2 levels until the postmenopausal group (P<0.001).
与育龄妇女比较 ,月经周期第 3天Inh B水平的下降仅在无排卵与绝经后妇女差异有极显著性 (P =0 0 0 1)。
10. Data collection employ a convenience sampling approach, targeting 11 postmenopausal women who did not pursued regular exercise in the south area of Taiwan.
个案之收集采方便取样法，以台湾南部地区11位无规律运动之停经后妇女为对象进行研究。
11. The clinical manifestations include irregular uterine bleeding,large menstrual blood volume,infertility,postmenopausal bleeding,and symptomless.
临床表现可为子宫不规则出血,或月经量多、不孕、绝经后出血等,也可无明显症状。
12. To investigate further, the researchers studied 626 postmenopausal women with LDL cholesterol levels of at least 130 mg/dL.
为了进一步的研究，研究者们研究了626位绝经后妇女，这些妇女的低密度脂蛋白的水平至少是130mg/dL。
13. "These data support and confirm that DHEA must be considered a valid compound and drug for [hormone therapy] in postmenopausal women and not just a 'dietary supplement,' " they add.
他们补充说明这些资料支持并证实需考虑将DHEA作为更年期妇女荷尔蒙疗法中有效的化合物与药物而并非只是饮食方面的补充。
14. Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides.
伴甘油三酯升高的绝经后肥胖女性应用贝特类降脂药与激素替代治疗降血脂的疗效对比研究。
15. The authors wrote that millions of postmenopausal women take multivitamins, many of them in the hope that they will prevent chronic diseases like cancer and cardiovascular disease.
作者称，数百万的绝经后妇女应用多种维生素，多数是希望能够预防慢性疾病如癌症和心血管疾病的发生。
16. Bisphosphonates are the most commonly used treatment for postmenopausal osteoporosis.
其双膦酸盐通常用于患有骨质疏松症的绝经期妇女的治疗。
17. Researchers at the University of California, San Francisco (UCSF;USA) conducted a three-year international study of 7,736 postmenopausal women with osteoporosis.
加州大学的研究者发起了一项为期三年的国际性的研究，此研究涉及7,736名绝经后妇女。
18. Doctors also urge women to keep their weight down, as obesity increases the risk of developing breast cancer during the postmenopausal years.
医生们也敦促女性减肥，因为肥胖会增加绝经后发生乳腺癌的风险。
19. Colditz GA. The use of estrogen and prosgestins and the risk of breast cancer in postmenopausal women. N Engl J Med, 1995,332:1589.
卢飙,邱明才,郑虎等.四环素-雌酮和雌酮作用去势大鼠的骨形态计量学对照研究.中华妇产科杂志,1998,33:31-34.
20. But the combination of antidepressant and estrogen is the best solution for the treatment of perimenopausal and postmenopausal depressive disorder, and the therapy must be individual.
受雌激素水平的影响，在原来抗抑郁药物的基础上，联合应用雌激素对提高疗效的作用更明显。
21. Meanwhile newer drugs that inhibit the aromatase enzyme, suppressing natural estrogen manufacture in the body, have proved superior to tamoxifen in postmenopausal women.
另一方面，有一种可抑制芳香酶从而阻止人体制造雌性素的新药，对停经后乳癌病患的效果又更胜于泰莫西芬。
22. The women included in this study were also compared with a group of postmenopausal women without a fracture history who had been included in another cohort study.
同时将本研究中的女性患者与另一项队列研究中未发生骨折的绝经后妇女进行对比。
23. Thus, we aimed to study the effects of testosterone addition on breast cell proliferation during postmenopausal estrogen/progestogen therapy.
因此，我们目的是研究绝经后雌激素/孕激素治疗期间联合雄性激素对乳腺细胞增殖效应。
24. Clinical Analysis Of 126 Perimenopausal And Postmenopausal Women With Adnexal Masses.
围绝经期及绝经后妇女附件包块126例临床分析
25. Here is a normal uterus with fallopian tubes and ovaries from an older postmenopausal woman.
图示：一绝经女性正常的子宫、输卵管及卵巢。
26. In 2,757 postmenopausal women with confirmed asthma, 23% reported estrogen use, 18% reported combined estrogen-progestin use, and 19% reported past HRT use.
在2,757名被确定为气喘的停经期后的妇女中，据报导：有23%使用了动情激素，有18%同时使用动情激素和黄体激素，有19%过去进行了荷尔蒙替代疗法。
27. In this latest study assessing oarian cancer risk, researchers looked at 948,576 postmenopausal women who did not hae preious cancer or bilateral oophorectomy.
在最近这项评估卵巢癌风险的研究中，研究人员纳入948576名绝经后妇女，她们之前均没有患癌症，也没有行双侧卵巢切除术。
28. Multiple regression analysis showed that CTR genotypes were associated with FN BMD in postmenopausal women(P<0.05).
多元逐步回归分析提示,CTR基因型与绝经后妇女股骨颈BMD相关(P<0.05)。
29. "Estrogens are helpful in postmenopausal women," she said, but stressed that 2 published trials found that oral contraceptive use showed no benefit to bone health in anorexic women with amenorrhea.
她表示，雌性激素对于停经后妇女是有帮助的，但是，她强调，有两项已经发表的临床研究显示，口服避孕药物对于生理期不规律厌食症妇女的骨骼健康是没有帮助的。
30. Postmenopausal hormone (estrogen plus a progestin) therapy appears to increase risk modestly after only 3 yr of use.
实施绝经后激素（雌激素+黄体激素）疗法3年后，危险性稍有增加。
31. The effect was more pronounced on postmenopausal women, but young women also had a raised risk.
对绝经后的妇女效果更加明显，但是年轻的妇女同样有升高的危险。
32. Many of the known risk factors for postmenopausal osteoporosis exist in the cirrhotic population, such as excess alcohol intake, steroid use, poor nutrition, and hypogonadism.
尤其那些血色沉著病和胆道疾病患者虽无肝硬化但骨质疏松风险可能会更高。
33. Coombes RC,Hall E,Gibson LJ,et al.A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.N Engl J Med, 2004,350:1081.
张少华,江泽飞,宋三泰,等.泰索帝联合希罗达治疗蒽环类化疗失败复发转移性乳腺癌的临床研究.癌症进展,2004,2:217-220.
34. Wyeth believes the data from these nearly 1,000 women provide additional support for a favorable benefit to risk ratio for bazedoxifene in the prevention of postmenopausal osteoporosis.
惠氏相信，由接近1000名妇女获得的研究数据制作的这2份研究报告，将为苯卓昔芬在预防绝经后骨质疏松症过程中低副作用风险提供有力的支持。
35. Abstract: Objectives To investigate the correlation among estrogen, antioxidation and atherosclerotic plaque in premenopausal and postmenopausal women.
摘要 摘 要 目的：探讨绝经前后妇女雌激素水平、抗氧化能力与动脉粥样硬化斑块的关系。
36. Objective To evaluate the change of endometrium with mitotic index and proliferating cell nuclear antigen (PCNA) index during postmenopausal hormone replacement therapy (HRT).
摘要目的了解核分裂率与增殖细胞核抗原(PCNA)指数两项指标在监测子宫内膜变化中的作用。
37. Objective To explore the relationship between the clinical features of postmenopausal metrorrhagia and entity, and the value of hysteroscopy in its diagnosis.
摘要目的探讨绝经后子宫出血的临床特征与病种的关系，以及宫腔镜检查在绝经后子宫出血诊断中的价值。
38. Objective Study the effect of load-dropping form on simulation result of osteoporosis based on the numerical model of postmenopausal osteoporosis.
摘要目的数值模拟妇女绝经后的骨质疏松，研究载荷下降形式对妇女绝经后骨质疏松模拟结果的影响。
39. Objective: To investigate the influence of the level of sex hormone with postmenopausal osteoporosis women.
摘要目的：探讨绝经后妇女性激素水平的变化对骨质疏松的影响。
40. Dercum's disease is a rare clinical condition characterized by the development of multiple painful subcutaneous lipomas selectively at postmenopausal women.
摘要窦根氏病是一种相当罕见的疾病，此病之特徵为发生于停经后妇女的多发性疼痛皮下脂肪瘤。
41. Postmenopausal osteoporosis is a major public health concern.Many studies have been done involving exercise therapy and effect on BMD of postmenopausal women.
摘要绝经后骨质疏松症是一个重要的公共健康问题，有关运动疗法与绝经后妇女骨骼的研究越来越多。
42. Background and Purpose: Premenopausal females, like the postmenopausal ones, are at high risk of developing osteoporosis and related fractures.
摘要背景与目的：女性无论在停经前或停经后，都是骨质疏松与相关骨折的高危险群。
43. Strontium ranelate is a new available medicine in the treatment of osteoporosis possessing effective prevention and treatment for osteoporosis especially in the management of hone fracture induced by postmenopausal asteoporosis.
摘要雷奈酸锶是一种新近上市的治疗骨质疏松药物，能够有效预防和治疗骨质疏松症及绝经后妇女骨质疏松引起的骨折。
44. Hyperuricaemia and gout are predominant diseases of middle-aged men and postmenopausal women.
摘要高尿酸血症和痛风常发生在中年男性或停经后的妇女。
45. Abstract： Obesity has been become a risk factor for cancer including breast cancer in postmenopausal women,colorectal cancer,endometrial cancer,kidney cancer,oesophageal adenocarcinoma and so on.
摘要： 肥胖已成为一些肿瘤的危险因素，包括绝经后妇女的乳腺癌、结肠直肠癌、子宫内膜癌、肾细胞癌、食管腺癌等。
46. Abstract: Objective To compare the clinical characters of endometrial carcinoma between premenopausal and postmenopausal patients.
文章摘要: 目的比较分析绝经与未绝经妇女子宫内膜癌的临床与病理特点。
47. This paper reviewed the effects of soy isoflavones on cardiovascular disease,osteoporosis,obesity and breast cancer in postmenopausal women.
文章综述了近年来有关大豆异黄酮与绝经后妇女相关疾病的研究进展。
48. Methods 75 healthy postmenopausal women were divided into three groups, 20 with normal bone density (Group A), 20 with osteopenia (Group B) and 35 with osteoporosis (Group C), according to broadband ultrasound attenuation (BUA).
方法 75 例正常绝经后妇女按照宽波段超声衰减（BUA） 分成骨量正常组（A 组） 、骨量减少组（B组） 、骨质疏松组（C组）。
49. Methods The clinical data of 126 perimenopausal and postmenopausal patients with adnexal masses from January 1999 to January 2003 were analyzed retrospectively in our hospital. Results 114 of 126 patients underwent operative intervention.
方法 回顾性分析126例围绝经期及绝经后妇女附件包块的临床资料:结果126例中114例接受手术治疗,其中卵巢恶性肿瘤11例,占9.6%,以上皮来源为主(10例,占90.9%);
50. Methods:30 cases of postmenopausal osteoporosis (OP) were treated with Migu tablet(MGT).
方法:30例绝经后骨质疏松症患者均采用补肾中药密骨片治疗,疗程半年。
51. Methods We study the clinical characteristics in 251 patients with postmenopausal vaginal bleeding, and analyze their correlation.
方法对251例绝经后阴道出血的患者进行临床分析,并分析其相关性。
52. Methods The CTR genotypes were determined by PCR-RFLP in 240 postmenopausal women of Anhui.
方法应用PCR-RFLP方法测定240名绝经后妇女CTR基因型;
53. Methods 82 postmenopausal women were divided into the regroups according to BMDs measured at lumbar spine and proximal femur with dual-energy X-ray absorptionmeter.
方法应用双能X线骨密度仪测量82例绝经后妇女腰椎骨密度(BMD),按WHO标准,分为无骨质疏松组(NOP)、骨质疏松组(OP1)、骨质疏松伴骨折组(OP2)。
54. Methods Numerical model of postmenopausal osteoporosis was established based on the anisotropic bone remodelling model and mechanostat system combined with finite element method.
方法根据骨重建的力学调控和各向异性理论，结合有限元方法，构建绝经后骨质疏松症的数学模型。
55. Methods The polymerase chain reaction restriction fragment length polymorphism was used to detect VDR genotype in 40 patients with osteoporosis and 21 healthy postmenopausal women.
方法用聚合酶链反应限制性片段长度多态性技术检测了40例绝经后患骨质疏松症的妇女和21名同龄绝经后无骨质疏松症的妇女的维生素D受体基因多态性。
56. Method The cardiac hemodynamic parameters were measured by color Doppler echocardiography in 30 postmenopausal and 24 reproductive women.
方法采用超声多普勒诊断仪测定30例绝经妇女及24例育龄妇女的心脏血流动力学参数。
57. Compared with postmenopausal woman with no menopausal syndrome, serum FSH, LH levels increased statiscally (P<0.01) in women with symptoms, and serum E2 levels decreased with no significance (P＞0.05).
更年期综合征妇女较无更年期综合征妇女血清FSH、LH水平升高，有显著差异（P<0.01），E2水平降低，无显著意义（P＞0.05）。
58. A brief introduction was given to summarize the management of postmenopausal osteoporosis, mainly presenting hormone replacement therapy and its new viewpoint.
本文概括了以性激素补充治疗为主的综合预防及治疗措施,并阐述了性激素补充治疗防治骨质疏松的新进展。
59. The goal of this study was to analyze the potential risk factors determining no improvements after hormone therapy for postmenopausal women with hot flushes.
本研究将针对停经后妇女有更年期症状接受荷尔蒙疗法后，而自觉热潮红症状未改善，进行相关危险因子的分析。
60. In menopause and aged women, BUA showed a significantly decrease(P< 0.01), whereas it decreased only slightly in early postmenopausal women(P >0.05).
本组资料各参数中,超声振幅衰减平均值在绝经期由(66.9±5.6)dB/MHz急剧降至(65.0±4.5)dB/MHz(P<0.01),而绝经后早期下降相对平缓(P>0.05),但老年期开始又呈明显递减(P<0.01)。
61. In the study, 10 postmenopausal women volunteers underwent a baseline evaluation then received twice-daily subcutaneous injections of 1 mg of GHRH for three months.
本项研究有10位停经后妇女志愿参与，先经过基线评估，再接受每日两次的GHRH皮下注射，持续3个月。
62. Karlsson B,Granbery S,wikland M,et al.Transraqinal.Ultrasonqraphy of the endometrium in women with postmenopausal bleeding-anordic molticenter study.Am J Obstet Gyneeol; 1995,172(5):1488.
李书娴,高淑华.绝经后阴道出血患者诊断性刮宫前B超检测子宫内膜的价值.中华妇产科杂志,1997,32(1):31.
63. Letrozole may be used for postmenopausal women who have completed 5 yr of daily tamoxifen.
来曲唑可用于连续5年、每天服用三苯氧胺的绝经后妇女。
64. A postmenopausal hormone therapy trial conducted in Estonia indicates that hormone therapy does not improve women's quality of life.
来自爱沙尼亚的一项绝经期妇女激素治疗临床试验显示:激素治疗并不能提高妇女的生活质量。
65. In addition, postmenopausal hormone (PMH) use may increase the risk of GERD symptoms among overweight and obese women.
此外，超重和肥胖的妇女在绝经后使用激素可能增加胃食管返流病症状的出现机会。”
66. Such carcinomas are more likely to occur in postmenopausal women.
此癌多发生在绝经期妇女。
67. Do the premenopausal daughters of women with postmenopausal osteoporosis have lower peak bone mass?
母患骨质疏松的女儿呈低峰值骨量吗?
68. Waking up earlier than planned also increases through late perimenopause but decreases when women become postmenopausal.
比预计时间早醒在绝经晚期的发生率也会增加，但在绝经后又会减少。
69. The Breast International Group (BIG)1-98 Collaborative Group，A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer. N Engl J Med 2005;353:2747-57.
江泽飞内分泌失调中药方，宋三泰.乳腺癌的内分泌治疗，见：韩锐，孙燕主编，新世纪癌的化学预防与药物治疗.人民军医出版社（北京），2005年1月第1版：840
70. Confounding the results even more is the fact that calcium and vitamin D supplementation is now routine therapy for postmenopausal women to protect against bone fractures.
混淆了结果，事实是：补充钙和维生素是绝经妇女为防止骨折的日常疗法。
71. Now, tamoxifen is still the standard endocrine therapeutic drug for the premenopausal patients, but aromatase inhibitors can bring more benefit for the postmenopausal patients.
目前,三苯氧胺对绝经前患者仍是内分泌治疗的标准用药,但对绝经后患者应用芳香化酶抑制剂会有更大的效益。
72. At present, HRT is also the main treatment of postmenopausal,but we should fully understand the advantages and also the crisis of HRT.
目前性激素替代疗法(HRT)仍是绝经后骨质疏松症的主要治疗方法,但应全面、深刻地认识HRT的受益与风险。
73. Now, tamoxifen is still the standard endocrine therapeutic drug or the premenopausal patients, but aromatase inhibitors can bring more benefit for the postmenopausal patients.
目前，三苯氧胺对绝经前患者仍是内分泌治疗的标准用药，但对绝经后患者应用芳香化酶抑制剂会有更大的效益。
74. Objective:To investigate the situation of productive health of perimenopausal and postmenopausal women in Chongzhou by an epidemiological study and then to provide health care for these women was made.
目的 :通过对崇州市中老年妇女围绝经期生殖健康情况调查 ,为开展针对中老年妇女的生殖健康保健提供依据。
75. Objective To investigate the situation of reproductive health of perimenopausal and postmenopausal women in Chengdu and provide a basis for planning reproductive health care for these women.
目的 了解我市妇女的围绝经期和绝经后的生殖健康情况 ,为开展针对中老年妇女的生殖健康保健提供依据。
76. Objective To assess the effects of medroxyprogesterone acetate(MPA)upon bone mineral density (BMD)and biochemical bone markers in postmenopausal women.
目的 了解醋酸甲孕酮 (MPA)对绝经后妇女骨密度 (BMD)及骨代谢指标的影响。
77. Objective To analyze the CT appearance of centrum compression in postmenopausal patients with primary spinal osteoporosis.
目的:分析绝经后脊柱原发性骨质疏松椎体压缩的CT表现。
78. AIM:To evaluate the efficacy and safety of risedronic acid in the treatment of postmenopausal osteoporosis.
目的:探讨利塞膦酸治疗绝经后骨质疏松症的有效性和安全性。
79. Objective:To investigate the cause of postmenopausal uterine bleeding and its diagnosis and treatment.
目的:探讨绝经后子宫出血的病因及诊断和治疗的方法。
80. Objective: To investigate the relationship between the age, duration of menopause, time of bleeding and pathologic type in postmenopausal vaginal bleeding (PVB) .
目的:探讨绝经后阴道出血患者年龄、绝经年限、出血时间和病理类型的关系。
